首页> 外国专利> Method for treating or reducing nasal congestion associated with allergic rhinitis in a hypertensive patient, which includes administering a Pharmaceutical composition comprising or Loratadine and montelukastA pharmaceutically acceptable Salt.

Method for treating or reducing nasal congestion associated with allergic rhinitis in a hypertensive patient, which includes administering a Pharmaceutical composition comprising or Loratadine and montelukastA pharmaceutically acceptable Salt.

机译：在高血压患者中治疗或减轻与变应性鼻炎有关的鼻充血的方法，该方法包括施用包含氯雷他定和孟鲁司特的药学上可接受的盐的药物组合物。

页面导航

摘要
著录项
相似文献

摘要

Methods for treating, preventing or reducing nasal congestion associated with allergic rhinitis are provided. Methods may involve administering a therapeutically effective amount of a pharmaceutical composition including loratadine and montelukast or a pharmaceutically acceptable salt thereof.

机译：提供了用于治疗，预防或减轻与变应性鼻炎有关的鼻充血的方法。方法可以包括给予治疗有效量的药物组合物，包括氯雷他定和孟鲁司特或其药学上可接受的盐。

著录项

公开/公告号CL2007003750A1

专利类型
公开/公告日2008-08-01

原文格式PDF
申请/专利权人 SCHERING CORPORATION;
展开▼

申请/专利号CL20070003750
发明设计人 DANZIG MELVYN RICHARD;
展开▼

申请日2007-12-20
分类号A61K31/435;A61K31/4545;A61P11/00;A61P11/02;
国家 CL
入库时间 2022-08-21 20:08:35

相似文献

专利
外文文献